Metabolium names COO
This article was originally published in Scrip
Romainville, France-based Metabolium has named Dr Khadidja Romari chief operating officer and chief scientific director. Before joining the company, Dr Romari spent several months as scientific advisor to Dominique Duvauchelle, CEO of Metabolium, to gain an understanding of the technologies developed by the company. Her new role will focus on developing Metabolium's product portfolio and raising its international profile to secure new partnerships. Before joining Metabolium, Dr Romari helped to develop American companies such as Bigelow Laboratory for Ocean Sciences, Albany Molecular Research and Targeted Growth.
You may also be interested in...
In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.
As the COVID-19 pandemic escalates, companies across the world are preparing to roll out commercial test kits for the detection of SARS-CoV-2.
Biopharmaceutical companies doubled-down on rare disease treatments during the last five years, thanks to a potent combination of scientific discovery and appealing business incentives.